Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat.
Mammalian ovulation is a dynamic process that requires degradation of the collagenous connective tissue in the thecal layers of a mature follicle. In this reverse transcription-polymerase chain reaction differential display study, gonadotropin-primed immature rats were used to detect ovarian expression of a relatively new type of disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS-1) that is known to cleave extracellular matrix in acutely inflamed tissues. Immature Wistar rats were primed with 10 IU eCG s. c., and the temporal pattern of expression of the ADAMTS-1 gene was delineated by extracting ovarian RNA at 0, 2, 4, 8, 12, and 24 h after induction of ovulation by injecting the primed animals with 10 IU hCG s.c. The differential display data, Northern analyses, and in situ hybridization micrographs all showed significant up-regulation of ADAMTS-1 gene expression by 8 h after hCG administration. The in situ data indicated that the ADAMTS-1 mRNA was in the granulosa layer of mature follicles. Expression reached a peak at 12 h and remained elevated at 24 h after hCG. ADAMTS-1 gene expression was impaired by the antiprogesterone agent epostane, but this inhibition could be overcome by exogenous progesterone. ADAMTS-1 expression was not affected when ovulation was blocked by treatment of the animals with the anti-eicosanoid agent indomethacin. In conclusion, the temporal pattern of expression of this gene, and its apparent regulation by progesterone, suggests that ADAMTS-1 has a significant role in the inflammatory events of the ovulatory process.
Espey
L L
LL
Department of Biology, Trinity University, San Antonio, Texas 78212, USA. lespey@trinity.edu
Yoshioka
S
S
Russell
D L
DL
Robker
R L
RL
Fujii
S
S
Richards
J S
JS
D051722:ADAM Proteins; D000071097:ADAMTS1 Protein; D000737:Androstenols / Q000494:pharmacology; D000818:Animals; D015152:Blotting, Northern; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D053938:DNA Fragmentation / Q000187:drug effects; D019483:Disintegrins / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006062:Gonadotropins / Q000494:pharmacology*; D017403:In Situ Hybridization; D007213:Indomethacin / Q000494:pharmacology; D008666:Metalloendopeptidases / Q000235:genetics / Q000378:metabolism*; D010053:Ovary / Q000378:metabolism*; D010060:Ovulation / Q000502:physiology*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019699:Thrombospondins / Q000378:metabolism*
D000737:Androstenols; D016861:Cyclooxygenase Inhibitors; D019483:Disintegrins; D006062:Gonadotropins; D012333:RNA, Messenger; D019699:Thrombospondins; C046855:epostane; D051722:ADAM Proteins; D000071097:ADAMTS1 Protein; C486324:Adamts1 protein, rat; D008666:Metalloendopeptidases; D007213:Indomethacin